Evoke Pharma Initiates Commercial Manufacturing of Gimoti™
July 15, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma Extends Cash Runway to 2Q 2021
July 08, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
FDA Approves Evoke’s GIMOTI™
June 19, 2020 15:32 ET
|
Evoke Pharma, Inc.
Commercial Partner EVERSANA Prepares for GIMOTI LaunchEvoke Extends Cash Runway into 2021 SOLANA BEACH, Calif., June 19, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty...
Evoke Receives FDA Conditional Acceptance of Gimoti Brand Name Following NDA Resubmission
May 20, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced...
Evoke Pharma Reports First Quarter 2020 Financial Results and Changes its 2020 Annual Meeting of Stockholders to a Virtual Format
May 12, 2020 08:30 ET
|
Evoke Pharma, Inc.
Gimoti™ Prescription Drug User Fee Act (PDUFA) date is June 19, 2020 SOLANA BEACH, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company...
Evoke Pharma Reports Fourth Quarter and Full Year 2019 Financial Results
March 12, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., March 12, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma Receives Notice of Allowance from USPTO for Gimoti™
January 27, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...
Evoke Pharma Enters Commercialization Agreement with EVERSANA Life Sciences for Gimoti™
January 23, 2020 08:30 ET
|
Evoke Pharma, Inc.
EVERSANA to commercialize and distribute Gimoti in the U.S. EVERSANA to provide $5 million revolving credit facility upon FDA approval SOLANA BEACH, Calif. and CHICAGO, Jan. 23, 2020 (GLOBE...
FDA Accepts Evoke Pharma’s NDA Resubmission for Gimoti™
January 21, 2020 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal (GI)...
Evoke Resubmits Gimoti™ New Drug Application to FDA
December 20, 2019 08:30 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...